Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

MHRA recall batches of insulin and sumatriptan injections

  • Print
  • Comment
  • Save

The Medicines and Healthcare products Regulatory Agency (MHRA) issued a drug alert today asking pharmacies and wholesalers to return some batches of sumatriptan injection- following a manufacturing fault which left some of the needles protruding from the protective shield.

The annoucement came just days after batches of NovoMix 30 insulin pens were also withdrawn die to concerns they contained the wrong dose of insulin.

The affected batches are:

• Imigran injection – C640404, C638748, C636954

• Imigran refill – C639899, C638737

• NovoMix 30 Flexpen 100U/ml pre-filled pen and the Novomix 30 Penfill 100U/ml cartridges - CS6D422, CS6C628, CS6C411, CP50912, CP50750, CP50639, CP51706, CP50940, CP50928, CP50903, CP50914, CP50640, CP51095, CP50904, CP50650, CP51098, CP50915, CP50412, CFG0003, CFG0002, CFG0001, CP50902, CP50749, CP50393, CP50950, CP51025, CP50751, CP50375, CP50420, CP51097, CP50641, CP51096 and CP50392

Have your say

  • Print
  • Comment
  • Save